Company: HMDCF
Filing Date: 2025-03-19
Form Type: 20-F
Source: 0001410578-25-000377
Chunk: 667

Company: HUTCHMED (China) Ltd
Filing Date: 2025-03-19
Form: 20-F
Item: Item 16K
Chunk 667
---
:

                               December 31,              
                                       2024        2023  
 ─────────────────────────────────────────────────────────
                             (in US$ ’ 000)              
  Not later than 1 year              23,372      31,155  
  Between 1 to 3 years                6,426       3,192  
  Between 3 to 4 years                8,033       2,872  
  Between 4 to 5 years               12,049       6,384  
  Later than 5 years                 32,926      35,741  
                                     82,806      79,344  

As at December 31, 2024 and 2023, the Group had aggregate unutilized bank borrowing facilities of US$60,549,000and US$68,069,000respectively.

F-30

Table of Contents

16. Commitments and Contingencies

The Group had the following capital commitments:

                                       December 31,    
 ───────────────────────────────────────────────────────
                                       2024            
                                       (in US$ ’ 000)  
  Property, plant and equipment                        
  Contracted but not provided for      3,058           

The Group does not have any other significant commitments or contingencies.

17. Ordinary Shares

As at December 31, 2024, the Company is authorized to issue1,500,000,000ordinary shares.

Each ordinary share is entitled toonevote. The holders of ordinary shares are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors of the Company.

18. Share-based Compensation

  (i)      Share-based Compensation of the Company  
 ────────────────────────────────────────────────────

The Company conditionally adopted a share option scheme on April 24, 2015 (as amended on April 27, 2020) (the “ Hutchmed Share Option Scheme”). Pursuant to the Hutchmed Share Option Scheme, the Board of Directors of the Company may, at its discretion, offer any employees and directors (including Executive and Non-executive Directors but excluding Independent Non-executive Directors) of the Company, holding companies of the Company and any of their subsidiaries or affiliates, and subsidiaries or affiliates of the Company share options to subscribe for shares of the Company.

As at December 31, 2024, the aggregate number of shares issuable under the Hutchmed Share Option Scheme was41